The Access to Medicine Foundation checked whether 18 household-name pharmaceutical giants publicly report how much antibiotic discharge they release into the environment. Guess how many firms revealed that information. MADLEN DAVIES and SAM LOEWENBERG from the Bureau of Investigative Journalism report
The NHS is buying drugs from pharmaceutical companies in India whose dirty production methods are fuelling the rise of superbugs, write Andrew Wasley & Madlen Davies. There are no checks or regulations in place to stop this happening - even though the rapid growth in antibiotic resistant bacteria in India is spreading across the world, including to the UK and NHS hospitals.